Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Lilly Teams With GPCR-Focused Superluminal In Cardiometabolic Disease

Aug 14 2025

• By Joseph Haas

Deal Watch 2021 — • Source: Shutterstock

Related Companies

Eli Lilly and Company

Superluminal Medicines Inc.

Basilea Pharmaceutica Ltd.

Venatorx Pharmaceuticals, Inc.

CorMedix Inc.

Melinta Therapeutics, Inc.

SERB Pharmaceuticals

Y-mAbs Therapeutics Inc.

XOMA Royalty Corporation

Lava Therapeutics NV

HilleVax, Inc.

Turnstone Biologics Corp.

Kinnate Biopharma, Inc.

Pulmokine, Inc.

Seagen Inc.

Pfizer Inc.

Janssen Pharmaceutical Cos.

MaxCyte, Inc.

Adicet Bio Inc.

Anocca AB

Bausch Health Companies Inc.

DURECT Corporation

Rakovina Therapeutics, Inc.

Intas Pharmaceuticals Ltd.

Sitryx Therapeutics

Polpharma SA

Fresenius Kabi AG

Takeda Pharmaceutical Co. Ltd.

Medicus Pharma Ltd.

University of Pittsburgh

IMIDomics, Inc.

Formation Bio

Re-Vana Therapeutics Ltd.

Boehringer Ingelheim GmbH

More from Deal Watch

More from Deals

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window